期刊文献+

IL-1α和MMP-9在中耳胆脂瘤上皮中的表达 被引量:1

The expression of interleukin-1α and matrix metalloproteinase-9 in middle ear cholesteatoma
暂未订购
导出
摘要 目的研究白介素-1α(interleukin-1α,IL-1α)和基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)的表达,探讨二者与胆脂瘤侵袭破坏能力的关系。方法采用免疫组织化学SP法检测了IL-1α、MMP-9在21例后天继发性胆脂瘤上皮与10例胆脂瘤患者外耳道皮肤表皮中的表达。结果IL-1α和MMP-9在胆脂瘤上皮的阳性表达率明显高于外耳道皮肤表皮,差异具显著性(P<0.01,P<0.01);胆脂瘤上皮IL-1α、MMP-9表达均与胆脂瘤的侵袭破坏程度正相关(P<0.05,P<0.05);胆脂瘤上皮中IL-1α、MMP-9表达存在正相关性。结论IL-1α、MMP-9是介导胆脂瘤侵袭破坏行为的重要细胞因子。在体内IL-1α可能对MMP-9表达具有上调作用。 Objective To explore the effects of interleukin-1α (IL-1α) and matrix metalloproteinase-9 (MMP- 9) in middle ear cholesteatoma and to explore the correlation between their expression and the ability of destruction of cholesteatoma. Methods IL-1α and MMP-9 were determined immunohistochemically in the specimens from 21 cases cholesteatomas and 10 external ear skin of patients with cholesteatoma. Results The positive expression of IL-1α and MMP-9 in cholesteatoma epithelialium were increased greatly than that in external epidermis (P〈0.01). Statistical analysis showed that the agressive ability of cholesteatoma was significantly positively related to the expression of IL-1α and MMP-9 in cholesteatoma epithelialium(P〈0.05). Conclusion IL-1α and MMP-9 are important factors in inducing bone destruction of cholesteatoma. IL-1α maybe play a role in upregulating MMP-9 expression in middle ear cholesteatoma.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期495-497,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 白介素-1Α 基质金属蛋白酶-9 中耳 胆脂瘤 interleukin-1α matrix metalloproteinase-9 middle ear cholesteatoma
  • 相关文献

参考文献6

  • 1江超武,展鸿谋,王文惠,张林,金树珍,杨一兵,章宗籍.转化生长因子β1和即刻早期基因及p27在中耳胆脂瘤上皮中的表达[J].中华耳鼻咽喉科杂志,2004,39(4):211-215. 被引量:16
  • 2Schilling V, Negri B, Bujia J, et al. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear [J]. Am J Otol, 1992,13(4) :350-355.
  • 3Kim CS, Lee CH, Chung JW, et al. lnterleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas [J]. Acta Otolaryngol, 1996,116(2):302-306.
  • 4Bujia J, Kim C, Boyle D, et al. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma [J]. Laryngoscope,1996,106(2 Pt 1):217- 220.
  • 5Turner HE, Nagy Z, Esiri MM, et al. Role of matrix metolloproteinase-9 in pituitary tumor behavior [J]. J Clin Endocrinol Metab, 2000,85(8) :2931-2935.
  • 6Schmidt M, Grunsfelder P, Hoppe F. Induction of matrix metal- Ioproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts [J]. Eur Arch Otorhinolaryngol, 2000,257 (8):425- 429.

二级参考文献13

  • 1李厚恩,汪磊.表皮生长因子受体在胆脂瘤的异常表达[J].耳鼻咽喉(头颈外科),1996,3(4):195-198. 被引量:3
  • 2Shieh TJ,Ho KY,Kuo WR,et al.Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.Kaohsiung J Med Sci,1999,15:468-474.
  • 3Shiwa M,Kojima H,Moriyama H.Expression of transferming growth factor-alpha in cholesteatoma.J Laryngol Otol,1998,112:750-774.
  • 4Tanaka Y,Kojima H,Miyazaki H,et al.Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.Laryngoscope,1999,109(7 pt 1):1102-1107.
  • 5Sastry KV,Sharma C,Mann SB,et al.Aural cholesteatoma: Role of tumor necrosis factor-a in bone destruction.Am J Otol,1999,20:158-161.
  • 6Koto A,Ohashi Y,Masamoto H,et al.Interleukin-6 and tumor necrosis factor-alpha synthesize by cholesteatoma cells affect munociliary function in the Eustachian tube.Acta Otolaryngol Suppl,1998,53:890-897.
  • 7Milewski C,Fedorowski A,Stan AC,et al.Basic fibroblast growth factor b-TGF in the perimatrix of cholesteatoma.HNO,1998,46:804-808.
  • 8Bujia J,Kim C,Holly A,et al.Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma; an analysis of protein production and gene expression.Am J Otol,1996,17:203-206.
  • 9Chae SW,Song JJ,Suh HK,et al.Expression patterns of p27 and Ki67 in cholesteatoma epithelium.Laryngoscope,2000,110:1898-1901.
  • 10Bayazit YA,Karakok M,Ucak R,et al.Cyalin-dependent kinase inhibitor,p27,is associated with cholesteatoma.Laryngoscope,2001,111:1037-1041.

共引文献15

同被引文献15

  • 1Olszewska E,Chodynicki S,Chyczewski L.Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults[J].Otolaryngol Pol,2003,57(1):85-89.
  • 2Huisman MA,De Heer E,Grote JJ.Sustained extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling is related to increased p21 expression in cholesteatoma epithelium[J].Acta Otolaryngol,2005,125(2):134-140.
  • 3Holly A,Sitlinger M,Bujia J.Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma[J].Eur Arch Otorhinolaryngol,1995,252:366-369.
  • 4RaynovAM,ChoungYH,MoonSK,etal.Expression of female sex hormone receptors in human middle ear cholesteatoma[J].J Laryngol Otol,2005,119(12):941-945.
  • 5Saleh HA,Mills RP.Classification and staging of cholesteatoma[J].Clin Otol,1999,24:355-359.
  • 6Shimizu M,Saitoh Y,Ltob H.Immunohistochemical staining of Ha-ras oncogene product in normal,benign,and malignant human pancreatic tissues[J].Hum pathol,1990,21:607-612.
  • 7Asp J,Inerot S,Block JA,et al.Alterations in the regulatory pathway involving p16,pRb and CDK4 in human chondrosarcoma[J].J-Orthop-Res,2001,19(1):149-154.
  • 8Raynov AM,Moon SK,Choung YH,et al.Nucleoplasm staining patterns and cell cycle-associated expression of Ki67 in middle ear cholesteatoma[J].Am J Otolaryngol,2005,26(5):296-301.
  • 9Hassmann-Poznanska E,Skotnicka B,Dzieciol J.Markers of epidermal proliferation in middle ear cholesteatoma[J].Otolaryngol Pol,2003,57(4):505-511.
  • 10Tanaka Y,Kojima H,Miyazaki H,et al.Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium[J].Laryngoscope,1999,109:1102-1107.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部